Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Crisantaspase |
Inferred relationship |
Some |
|
Product containing crisantaspase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Crisantaspase |
Inferred relationship |
Some |
1 |
Crisantaspase poisoning of undetermined intent |
Causative agent (attribute) |
False |
Crisantaspase |
Inferred relationship |
Some |
1 |
Allergy to crisantaspase (finding) |
Causative agent (attribute) |
False |
Crisantaspase |
Inferred relationship |
Some |
|
Intentional crisantaspase overdose |
Causative agent (attribute) |
True |
Crisantaspase |
Inferred relationship |
Some |
1 |
Crisantaspase overdose |
Causative agent (attribute) |
True |
Crisantaspase |
Inferred relationship |
Some |
1 |
Crisantaspase overdose of undetermined intent |
Causative agent (attribute) |
False |
Crisantaspase |
Inferred relationship |
Some |
1 |
Accidental crisantaspase poisoning |
Causative agent (attribute) |
True |
Crisantaspase |
Inferred relationship |
Some |
1 |
Intentional crisantaspase poisoning |
Causative agent (attribute) |
True |
Crisantaspase |
Inferred relationship |
Some |
1 |
Accidental crisantaspase overdose |
Causative agent (attribute) |
True |
Crisantaspase |
Inferred relationship |
Some |
1 |
Crisantaspase poisoning |
Causative agent (attribute) |
True |
Crisantaspase |
Inferred relationship |
Some |
1 |
Allergy to crisantaspase (finding) |
Causative agent (attribute) |
True |
Crisantaspase |
Inferred relationship |
Some |
1 |
Product containing only crisantaspase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Crisantaspase |
Inferred relationship |
Some |
1 |
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Crisantaspase |
Inferred relationship |
Some |
1 |
Crisantaspase-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Crisantaspase |
Inferred relationship |
Some |
1 |
Crisantaspase only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Crisantaspase |
Inferred relationship |
Some |
1 |
Crisantaspase adverse reaction |
Causative agent (attribute) |
True |
Crisantaspase |
Inferred relationship |
Some |
1 |
Product containing precisely crisantaspase 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Crisantaspase |
Inferred relationship |
Some |
1 |
Product containing precisely crisantaspase 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Crisantaspase |
Inferred relationship |
Some |
1 |